3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Biphenotypic, Acute
1
Hematologic Diseases
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Whole-Body Irradiation
5
Cyclophosphamide
5
fludarabine phosphate
4
Busulfan
4
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Melphalan
3
Cyclosporine
3
venetoclax
2
fludarabine
2
Tacrolimus
2
Specimen Handling
2
Methotrexate
2
Etoposide
2
Biopsy
2
Azacitidine
2
Antilymphocyte Serum
2
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
Vorinostat
1
Thiotepa
1
TAK-243
1
Sirolimus
1
Rituximab
1
Lenalidomide
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Cyclosporins
×
30 days
×
Clear all
No trials found.